 |
|
Intravenous Immunoglobulin Treatment for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
A Prospective Noncomparative Study Showing No Benefit on Mortality or Progression
Nicolas Bachot, MD;
Jean Revuz, MD;
Jean-Claude Roujeau, MD
Arch Dermatol. 2003;139:33-36.
Background It has been proposed that Fas–Fas ligand interaction was responsible for the apoptosis of epidermal cells in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) and that high doses of intravenous immunoglobulin (IVIG) could help patients by blocking the apoptosis.
Objective To study the effects of IVIG on SJS and TEN.
Design Prospective open trial.
Setting Referral center of a university hospital.
Patients Thirty-four consecutive patients admitted for SJS (n = 9), SJS-TEN (n = 5), or TEN (n = 20) a mean of 4.3 days after onset.
Intervention A dose of 2 g/kg of IVIG was administered within 2 days (half doses or full doses over a longer period for patients with low creatinine clearance).
Main Outcome Measures Detached plus detachable proportions of the total body surface area measured before and after treatment and predicted death rate estimated on admission with a validated prognostic score.
Results Epidermal detachment involved a mean ± SD 19% ± 16% of the total body surface area on admission and 32% ± 26% after IVIG treatment (progression in 22 of 34 cases, including most patients referred early). The prognostic score predicted 8.2 deaths (24%); 11 were observed (32%; 95% confidence interval, 17%-51%). Most deaths occurred in elderly patients who had initially impaired renal function.
Conclusions The confidence interval of the observed death rate excludes a dramatic decrease in mortality. No measurable effect was observed on the progression of detachment or on the speed of reepidermalization. These results do not support the routine use of IVIG treatment for patients with SJS or TEN, especially in cases of impaired renal function.
From the Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLES
Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins: Multicenter Retrospective Analysis of 48 Consecutive Cases
Christa Prins, Francisco A. Kerdel, R. Steven Padilla, Thomas Hunziker, Sergio Chimenti, Isabelle Viard, Davide N. Mauri, Kirsten Flynn, Jennifer Trent, David J. Margolis, Jean-Hilaire Saurat, Lars E. French, and for the TEN-IVIG Study Group
Arch Dermatol. 2003;139(1):26-32.
ABSTRACT
| FULL TEXT
Analysis of Intravenous Immunoglobulin for the Treatment of Toxic Epidermal Necrolysis Using SCORTEN: The University of Miami Experience
Jennifer T. Trent, Robert S. Kirsner, Paolo Romanelli, and Francisco A. Kerdel
Arch Dermatol. 2003;139(1):39-43.
ABSTRACT
| FULL TEXT
Treatment of Toxic Epidermal Necrolysis: The Uncertainty Persists but the Fog Is Dispersing
Klaus Wolff and Gerhard Tappeiner
Arch Dermatol. 2003;139(1):85-86.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection
Borras-Blasco et al.
J Antimicrob Chemother 2008;62:879-888.
ABSTRACT
| FULL TEXT
Management of toxic epidermal necrolysis and related syndromes
Mukasa and Craven
Postgrad. Med. J. 2008;84:60-65.
ABSTRACT
| FULL TEXT
Treatment of Anticonvulsant Hypersensitivity Syndrome with Intravenous Immunoglobulins and Corticosteroids
Prais et al.
J Child Neurol 2006;21:380-384.
ABSTRACT
Case 34-2005 -- A 10-Year-Old Girl with a Bullous Skin Eruption and Acute Respiratory Failure.
Sheridan et al.
NEJM 2005;353:2057-2066.
FULL TEXT
Cell-Mediated Immunologic Mechanism and Severity of TEN
Faye et al.
Arch Dermatol 2005;141:775-776.
FULL TEXT
The Contribution of the Fas/FasL Apoptotic Pathway in Ulcer Formation during Leishmania major-Induced Cutaneous Leishmaniasis
Eidsmo et al.
Am. J. Pathol. 2005;166:1099-1108.
ABSTRACT
| FULL TEXT
Stevens-Johnson Syndrome After Immunization With Smallpox, Anthrax, and Tetanus Vaccines
Chopra et al.
Mayo Clin Proc. 2004;79:1193-1196.
ABSTRACT
Spectrum of Anticonvulsant Hypersensitivity Syndrome: Controversy of Treatment
Lee et al.
J Child Neurol 2004;19:619-623.
ABSTRACT
Use of SCORTEN to Accurately Predict Mortality in Patients With Toxic Epidermal Necrolysis in the United States
Trent et al.
Arch Dermatol 2004;140:890-892.
FULL TEXT
Use of Intravenous Immunoglobulin in Children With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Seven Cases and Review of the Literature
Metry et al.
Pediatrics 2003;112:1430-1436.
ABSTRACT
| FULL TEXT
Scoring With SCORTEN
Collin et al.
Arch Dermatol 2003;139:1215-1215.
FULL TEXT
IVIg Helps SJS/TEN; No It Doesn't ; Yes It Does
Journal Watch Dermatology 2003;2003:5-5.
FULL TEXT
Treatment of Toxic Epidermal Necrolysis: The Uncertainty Persists but the Fog Is Dispersing
Wolff and Tappeiner
Arch Dermatol 2003;139:85-86.
FULL TEXT
|
